Summary of Chronic

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

Chronic summary
Start getting smarter:
or see our plans

Rating

8

Qualities

  • Eye Opening
  • Concrete Examples
  • Engaging

Recommendation

At the heart of the pharmaceutical industry lies a paradox: Devoted to helping people get well, the drug industry depends on patients staying sick. Clayton Dalton, a resident at the Massachusetts General Hospital in Boston, traces the economic forces that influence research and treatment choices for chronic disease. For anyone interested in the business of health and disease, getAbstract recommends Dalton’s analysis of the interactions of money and medicine.

About the Author

Clayton Dalton is a medical resident at the Massachusetts General Hospital in Boston. 

 

Summary

Most of the world’s drug development happens in market economies, where financial incentives distort choices about where to spend research dollars. In April 2018, for example, a Goldman Sachs report advised companies in the drug and biotech industries to avoid investments in medicines that cure disease. Drug companies profit more from drugs that only control conditions, so that patients have to take the drugs for the rest of their lives. Legislation can modify financial incentives and thereby redirect investments in medical research and treatment. In one example, the 1982 Orphan...


More on this topic

Customers who read this summary also read

Forget the Blood of Teens
8
The Pain Refugees
8
7 Amazing Ways Artificial Intelligence Is Used in Healthcare
8
How VR Could Break America’s Opioid Addiction
8
The Return of Racism?
7
The Lawyer Who Beat Big Tobacco Takes on the Opioid Industry
8

Related Channels

Comment on this summary